295
Views
7
CrossRef citations to date
0
Altmetric
PRECOCIOUS PUBERTY

Inhibin B as a screening tool for early detection and treatment monitoring of central precocious puberty

, , , ORCID Icon, &
Pages 768-771 | Received 10 Oct 2019, Accepted 16 Jan 2020, Published online: 12 Mar 2020

References

  • Jeppesen JV, Anderson RA, Kelsey TW, et al. Which follicles make the most anti-Mullerian hormone in humans? Evidence for an abrupt decline in AMH production at the time of follicle selection. Mol Hum Reprod. 2013;19(8):519–527.
  • Hagen CP, Mouritsen A, Mieritz MG, et al. Circulating AMH reflects ovarian morphology by magnetic resonance imaging and 3D ultrasound in 121 healthy girls. J Clin Endocrinol Metabol. 2015;100(3):880–890.
  • Weenen C, Laven JS, Von Bergh AR, et al. Anti-Mullerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. Mol Hum Reprod. 2004;10(2):77–83.
  • Taguchi O, Cunha GR, Lawrence WD, et al. Timing and irreversibility of Mullerian duct inhibition in the embryonic reproductive tract of the human male. Dev Biol. 1984;106(2):394–398.
  • Pellatt L, Rice S, Mason HD. Anti-Mullerian hormone and polycystic ovary syndrome: a mountain too high? Reproduction. 2010;139(5):825–833.
  • Hagen CP, Aksglaede L, Sorensen K, et al. Individual serum levels of anti-Mullerian hormone in healthy girls persist through childhood and adolescence: a longitudinal cohort study. Hum Reprod. 2012;27(3):861–866.
  • van Zonneveld P, Scheffer GJ, Broekmans FJ, et al. Do cycle disturbances explain the age-related decline of female fertility? Cycle characteristics of women aged over 40 years compared with a reference population of young women. Hum Reprod. 2003;18(3):495–501.
  • Chada M, Průsa R, Bronský J, et al. Inhibin B, follicle stimulating hormone, luteinizing hormone, and estradiol and their relationship to the regulation of follicle development in girls during childhood and puberty. Physiol Res. 2003;52(3):341–346.
  • Groome NP, Illingworth PJ, O’Brien M, et al. Measurement of dimeric inhibin B throughout the human menstrual cycle. J Clin Endocrinol Metabol. 1996;81(4):1401–1405.
  • Sehested A, Juul AA, Andersson AM, et al. Serum inhibin A and inhibin B in healthy prepubertal, pubertal, and adolescent girls and adult women: relation to age, stage of puberty, menstrual cycle, follicle-stimulating hormone, luteinizing hormone, and estradiol levels. J Clin Endocrinol Metab. 2000;85(4):1634–1640.
  • Marshall WA, Tanner JM. Variations in pattern of pubertal changes in girls. Arch Dis Childhood. 1969;44(235):291–303.
  • Greulich WW, Pyle SI. Radiographic atlas of skeletal development of the hand and wrist. Am J Med Sci. 1959;238(3):393.
  • Moon JS, Lee SY, Nam CM, et al. 2007 Korean National Growth Charts: review of developmental process and an outlook. Korean J Pediatr DE Pediatr. 2008;51(1):1–25.
  • Sehested A, Andersson AM, Muller J, et al. Serum inhibin A and inhibin B in central precocious puberty before and during treatment with GnRH agonists. Horm Res Paediatr. 2000;54(2):84–91.
  • De Filippo G, Rendina D, Nazzaro A, et al. Baseline inhibin B levels for diagnosis of central precocious puberty in girls. Horm Res Paediatr. 2013;80(3):207–212.
  • Chen T, Wu H, Xie R, et al. Serum anti-Mullerian hormone and inhibin B as potential markers for progressive central precocious puberty in girls. J Pediatr Adol Gynec. 2017;30(3):362–366.
  • Grinspon RP, Ropelato MG, Bedecarras P, et al. Gonadotrophin secretion pattern in anorchid boys from birth to pubertal age: pathophysiological aspects and diagnostic usefulness. Clin Endocrinol. 2012;76(5):698–705.
  • Grinspon RP, Andreone L, Bedecarras P, et al. Male central precocious puberty: serum profile of anti-Mullerian hormone and inhibin B before, during, and after treatment with GnRH analogue. Int J Endocrinol. 2013;2013:1–6.
  • Hagen CP, Sorensen K, Anderson RA, et al. Serum levels of antimullerian hormone in early maturing girls before, during, and after suppression with GnRH agonist. Fertil Steril. 2012;98(5):1326–1330.
  • Nam HK, Kim HR, Rhie YJ, et al. Serum anti-Mullerian hormone levels in precocious puberty girls according to stage of GnRH agonist treatment. J Korean Med Sci. 2017;32(3):475–479.
  • Savas-Erdeve S, Sagsak E, Keskin M, et al. AMH levels in girls with various pubertal problems. J Pediatr Endocrinol Metab. 2017;30(3):333–335.
  • Lashen H, Dunger DB, Ness A, et al. Peripubertal changes in circulating antimullerian hormone levels in girls. Fertil Steril. 2013;99(7):2071–2075.
  • de Vet A, Laven JS, de Jong FH, et al. Antimullerian hormone serum levels: a putative marker for ovarian aging. Fertil Steril. 2002;77(2):357–362.
  • Wachs DS, Coffler MS, Malcom PJ, et al. Serum anti-mullerian hormone concentrations are not altered by acute administration of follicle stimulating hormone in polycystic ovary syndrome and normal women. J Clin Endocrinol Metabol. 2007;92(5):1871–1874.
  • Singer T, Barad DH, Weghofer A, et al. Correlation of anti-Mullerian hormone and baseline follicle-stimulating hormone levels. Fertil Steril. 2009;91(6):2616–2619.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.